Helen E. Connor

2.3k total citations
49 papers, 2.0k citations indexed

About

Helen E. Connor is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Helen E. Connor has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 20 papers in Physiology. Recurrent topics in Helen E. Connor's work include Neuropeptides and Animal Physiology (20 papers), Migraine and Headache Studies (15 papers) and Receptor Mechanisms and Signaling (14 papers). Helen E. Connor is often cited by papers focused on Neuropeptides and Animal Physiology (20 papers), Migraine and Headache Studies (15 papers) and Receptor Mechanisms and Signaling (14 papers). Helen E. Connor collaborates with scholars based in United Kingdom, Sweden and Switzerland. Helen E. Connor's co-authors include W. Feniuk, P.P.A. Humphrey, David T. Beattie, M.J. Perren, Eric T. Whalley, A. W. Oxford, Darko Butina, D. I. C. SCOPES, M. Skingle and Andrew A. Parsons and has published in prestigious journals such as Gastroenterology, Brain and Analytical Biochemistry.

In The Last Decade

Helen E. Connor

49 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Helen E. Connor 914 816 800 630 452 49 2.0k
Inger Jansen‐Olesen 2.1k 2.3× 1.1k 1.4× 1.1k 1.4× 629 1.0× 1000 2.2× 100 3.2k
Christopher S. Walker 1.0k 1.1× 467 0.6× 1.1k 1.4× 673 1.1× 396 0.9× 57 2.1k
Alexander A. Velumian 199 0.2× 370 0.5× 1.4k 1.7× 1.0k 1.7× 368 0.8× 32 2.3k
Siro Luvisetto 331 0.4× 1.0k 1.3× 801 1.0× 907 1.4× 187 0.4× 63 2.3k
S J Peroutka 308 0.3× 342 0.4× 712 0.9× 463 0.7× 129 0.3× 17 1.3k
Peter Sneddon 180 0.2× 639 0.8× 878 1.1× 1.2k 1.8× 56 0.1× 40 2.5k
M. Markerink–van Ittersum 191 0.2× 549 0.7× 516 0.6× 876 1.4× 37 0.1× 43 1.8k
Edward C. Burgard 168 0.2× 261 0.3× 925 1.2× 684 1.1× 70 0.2× 39 1.9k
Thomas Kleppisch 90 0.1× 727 0.9× 1.1k 1.3× 1.7k 2.7× 138 0.3× 38 2.6k
Steve C. Danzer 440 0.5× 231 0.3× 1.6k 1.9× 902 1.4× 70 0.2× 75 3.3k

Countries citing papers authored by Helen E. Connor

Since Specialization
Citations

This map shows the geographic impact of Helen E. Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Connor more than expected).

Fields of papers citing papers by Helen E. Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen E. Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Connor. The network helps show where Helen E. Connor may publish in the future.

Co-authorship network of co-authors of Helen E. Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Helen E. Connor. A scholar is included among the top collaborators of Helen E. Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen E. Connor. Helen E. Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goadsby, Peter J., et al.. (2002). Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain. 125(6). 1392–1401. 78 indexed citations
2.
3.
Perren, M.J., et al.. (1997). The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system. Regulatory Peptides. 68(1). 23–29. 31 indexed citations
4.
Perren, M.J., Helen E. Connor, & David T. Beattie. (1996). NK1 and CGRP receptor-mediated dilatation of the carotid arterial bed of the anaesthetized rabbit. Neuropeptides. 30(2). 141–148. 5 indexed citations
5.
Skingle, M., David T. Beattie, D. I. C. SCOPES, et al.. (1995). GR127935: a potent and selective 5-HT1D receptor antagonist. Behavioural Brain Research. 73(1-2). 157–161. 155 indexed citations
6.
Escott, Katherine J., Helen E. Connor, Susan D. Brain, & David T. Beattie. (1995). The involvement of calcitonin gene-related peptide (CGRP) and substance P in feline pial artery diameter responses evoked by capsaicin. Neuropeptides. 29(3). 129–135. 21 indexed citations
7.
Beattie, David T., I.J.M. Beresford, Helen E. Connor, et al.. (1995). The pharmacology of GR203040, a novel, potent and selective non‐peptide tachykinin NK1 receptor antagonist. British Journal of Pharmacology. 116(8). 3149–3157. 56 indexed citations
8.
Beattie, David T., et al.. (1995). The activity of 5-HT1D receptor ligands at cloned human 5-HT1Dα and 5-HT1Dβ receptors. European Journal of Pharmacology. 287(1). 79–84. 46 indexed citations
9.
O’Shaughnessy, Celestine T. & Helen E. Connor. (1994). Activation of sensory nerves in guinea-pig isolated basilar artery by nicotine: evidence for inhibition of trigeminal sensory neurotransmission by sumatriptan. European Journal of Pharmacology. 259(1). 37–42. 10 indexed citations
10.
CLITHEROW, J. W., D. I. C. SCOPES, M. Skingle, et al.. (1994). Evolution of a Novel Series of [(N,N-Dimethylamino)propyl]- and Piperazinylbenzanilides as the First Selective 5-HT1D Antagonists. Journal of Medicinal Chemistry. 37(15). 2253–2257. 89 indexed citations
11.
Beattie, David T. & Helen E. Connor. (1994). The influence of the trigeminal ganglion on carotid blood flow in anaesthetized guinea‐pigs. British Journal of Pharmacology. 112(1). 262–266. 19 indexed citations
12.
O'Shaughnessy, C.T., et al.. (1993). Sensory nerve‐mediated relaxation of guinea‐pig isolated pulmonary artery: prejunctional modulation by α2‐adrenoceptor agonists but not sumatriptan. British Journal of Pharmacology. 109(1). 126–130. 14 indexed citations
13.
O'Shaughnessy, C.T., Gareth Waldron, & Helen E. Connor. (1993). Lack of effect of sumatriptan and UK‐14,304 on capsaicin‐induced relaxation of guinea‐pig isolated basilar artery. British Journal of Pharmacology. 108(1). 191–195. 21 indexed citations
14.
Stubbs, Carole M., Gareth Waldron, Helen E. Connor, & W. Feniuk. (1992). Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation. British Journal of Pharmacology. 105(4). 875–880. 17 indexed citations
15.
Feniuk, W., P.P.A. Humphrey, M.J. Perren, Helen E. Connor, & Eric T. Whalley. (1991). Rationale for the use of 5-HT1-like agonists in the treatment of migraine. Journal of Neurology. 238(S1). S57–S61. 50 indexed citations
16.
Stubbs, Carole M., Helen E. Connor, & W. Feniuk. (1991). BMY 7378 is an agonist at 5-HT1A receptors mediating hypotension and renal sympatho-inhibition in anaesthetised cats. European Journal of Pharmacology. 197(1-2). 113–116. 15 indexed citations
17.
Parsons, Andrew A., Eric T. Whalley, W. Feniuk, Helen E. Connor, & P.P.A. Humphrey. (1989). 5‐HT1‐like receptors mediate 5‐hydroxytryptamine‐induced contraction of human isolated basilar artery. British Journal of Pharmacology. 96(2). 434–449. 143 indexed citations
18.
Connor, Helen E. & W. Feniuk. (1989). Influence of the endothelium on contractile effects of 5‐hydroxytryptamine and selective 5‐HT agonists in canine basilar artery. British Journal of Pharmacology. 96(1). 170–178. 45 indexed citations
19.
Connor, Helen E., Robert Edwards, & W. Feniuk. (1989). Neurogenically mediated contractions of dog basilar artery involve the release of a thromboxane-like substance. European Journal of Pharmacology. 174(2-3). 205–213. 4 indexed citations
20.
Connor, Helen E., W. Feniuk, & P.P.A. Humphrey. (1989). Characterization of 5‐HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5‐HT1‐like receptor agonist. British Journal of Pharmacology. 96(2). 379–387. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inger Jansen‐Olesen Breakdown of academic impact, for papers by Christopher S. Walker Breakdown of academic impact, for papers by Alexander A. Velumian Breakdown of academic impact, for papers by Siro Luvisetto Breakdown of academic impact, for papers by S J Peroutka Breakdown of academic impact, for papers by Peter Sneddon Breakdown of academic impact, for papers by M. Markerink–van Ittersum Breakdown of academic impact, for papers by Edward C. Burgard Breakdown of academic impact, for papers by Thomas Kleppisch Breakdown of academic impact, for papers by Steve C. Danzer
Rankless by CCL
2026